Trials / Completed
CompletedNCT00517842
A Triple-blinded, Randomised, Placebo-controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients With Parkinson's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (estimated)
- Sponsor
- Hospital Authority, Hong Kong · Other Government
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- —
Summary
The investigational product is a specially formulated TCM and administered in the form of a capsule. Basic pre-clinical studies have suggested that it may have good immunomodulating functions, increases the activities of T-cells, B-cells and NK cells, enhances mitochondrial antioxidant status on various tissues including brain tissues. Therefore, this formulation may have special values in improving symptoms in Parkinson's disease patients. The purpose of the study is to determine the efficacy and safety of ViNeuro in patients with Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ViNeuro |
Timeline
- Start date
- 2005-10-01
- Completion
- 2008-09-01
- First posted
- 2007-08-17
- Last updated
- 2013-09-05
Locations
5 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00517842. Inclusion in this directory is not an endorsement.